Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis.
作者信息
Rothenberg Marc E, Aceves Seema, Bonis Peter A, Collins Margaret H, Gonsalves Nirmala, Gupta Sandeep K, Hirano Ikuo, Liacouras Chris A, Putnam Phil E, Spergel Jonathan M, Straumann Alex, Wershil Barry K, Furuta Glenn T
出版信息
J Allergy Clin Immunol. 2012 Sep;130(3):617-9. doi: 10.1016/j.jaci.2012.06.051.
Abstract
摘要
相似文献
1
Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis.与美国食品药品监督管理局合作：嗜酸性食管炎患者诊疗的进展与时间安排
J Allergy Clin Immunol. 2012 Sep;130(3):617-9. doi: 10.1016/j.jaci.2012.06.051.
2
Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases.嗜酸粒细胞性食管炎研究的跨部门赞助：罕见病合理药物开发的协作模式。
J Allergy Clin Immunol. 2012 Sep;130(3):613-6. doi: 10.1016/j.jaci.2012.07.011. Epub 2012 Jul 31.
3
Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration.开发嗜酸性粒细胞性食管炎的药物治疗方法：美国食品药品监督管理局的指导草案
Gastroenterology. 2019 Aug;157(2):275-277. doi: 10.1053/j.gastro.2019.04.020. Epub 2019 Apr 22.
4
Recent advances in potential targets for eosinophilic esophagitis treatments.嗜酸粒细胞性食管炎治疗靶点的最新进展。
Expert Rev Clin Immunol. 2020 Apr;16(4):421-428. doi: 10.1080/1744666X.2020.1742110. Epub 2020 Mar 18.
5
[The eosinophilic esophagitis and IgG4-related disease involving the esophagus].[嗜酸性粒细胞性食管炎及累及食管的IgG4相关性疾病]
Ter Arkh. 2020 Sep 3;92(8):100-107. doi: 10.26442/00403660.2020.08.000792.
6
Eosinophilic esophagitis: treatment with oral viscous budesonide.嗜酸性食管炎：口服粘性布地奈德治疗
Int J Pharm Compd. 2012 Jul-Aug;16(4):288-93.
7
[Eosinophilic esophagitis].[嗜酸性粒细胞性食管炎]
Presse Med. 2014 Jan;43(1):34-8. doi: 10.1016/j.lpm.2013.03.012. Epub 2013 Jul 23.
8
Eosinophilic esophagitis and food impaction: an instructive case.嗜酸性食管炎与食物嵌塞：一则有启发性的病例
Turk J Gastroenterol. 2012 Jun;23(3):294-7. doi: 10.4318/tjg.2012.0386.
9
Emerging drugs for eosinophilic esophagitis.用于嗜酸性食管炎的新兴药物。
Expert Opin Emerg Drugs. 2018 Jun;23(2):173-183. doi: 10.1080/14728214.2018.1483335. Epub 2018 Jun 8.
10
Omalizumab in the treatment of eosinophilic esophagitis and food allergy.奥马珠单抗治疗嗜酸性食管炎和食物过敏。
Eur J Pediatr. 2011 Nov;170(11):1471-4. doi: 10.1007/s00431-011-1540-4. Epub 2011 Aug 2.
引用本文的文献
1
Integrating PEESS, EREFS, and endoscopic ultrasonography in the multimodal management of pediatric eosinophilic esophagitis: A 4-year retrospective institutional experience.在儿童嗜酸性粒细胞性食管炎的多模式管理中整合儿科食管内镜下黏膜下注射类固醇（PEESS）、食管反流内镜评估量表（ERefs）和内镜超声检查：一项为期4年的机构回顾性经验。
Medicine (Baltimore). 2025 Aug 8;104(32):e43803. doi: 10.1097/MD.0000000000043803.
2
Building and implementing a research infrastructure for eosinophilic gastrointestinal diseases.构建并实施嗜酸性胃肠道疾病的研究基础设施。
J Allergy Clin Immunol. 2024 Jun;153(6):1536-1539. doi: 10.1016/j.jaci.2024.04.014.
3
Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis.嗜酸性食管炎新型疗法迈向新高度
Gastroenterology. 2024 Jan;166(1):1-10. doi: 10.1053/j.gastro.2023.09.004. Epub 2023 Sep 9.
4
Scientific journey to the first FDA-approved drug for eosinophilic esophagitis.科学之旅：首款获 FDA 批准用于嗜酸性食管炎的药物
J Allergy Clin Immunol. 2022 Dec;150(6):1325-1332. doi: 10.1016/j.jaci.2022.09.027. Epub 2022 Oct 6.
5
Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.吞咽局部用皮质类固醇治疗嗜酸性食管炎
World J Gastroenterol. 2020 Sep 28;26(36):5395-5407. doi: 10.3748/wjg.v26.i36.5395.
6
Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).通过嗜酸性粒细胞性胃肠病研究人员联合会（CEGIR）推进患者护理。
J Allergy Clin Immunol. 2020 Jan;145(1):28-37. doi: 10.1016/j.jaci.2019.11.012. Epub 2019 Nov 20.
7
A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.理解嗜酸性粒细胞性食管炎治疗反应的概念方法。
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2149-2160. doi: 10.1016/j.cgh.2019.01.030. Epub 2019 Jan 30.
8
Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis.复方口服粘性布地奈德对嗜酸性食管炎有效且疗效持久。
HSOA J Gastroenterol Hepatol Res. 2018;7(1):2509-2515. Epub 2018 Feb 21.
9
Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).创建一个多中心罕见病联盟——嗜酸性胃肠道疾病研究人员联盟（CEGIR）。
Transl Sci Rare Dis. 2017 Dec 18;2(3-4):141-155. doi: 10.3233/TRD-170016.
10
White Paper AGA: Drug Development for Eosinophilic Esophagitis.美国胃肠病学会白皮书：嗜酸性食管炎的药物研发
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1173-1183. doi: 10.1016/j.cgh.2017.03.016. Epub 2017 Mar 22.
本文引用的文献
1
Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases.嗜酸粒细胞性食管炎研究的跨部门赞助：罕见病合理药物开发的协作模式。
J Allergy Clin Immunol. 2012 Sep;130(3):613-6. doi: 10.1016/j.jaci.2012.07.011. Epub 2012 Jul 31.
2
Placebo and other interventions in asthma.哮喘中的安慰剂及其他干预措施。
N Engl J Med. 2011 Oct 13;365(15):1446-7; author reply 1447-8. doi: 10.1056/NEJMc1109235.
3
Active albuterol or placebo, sham acupuncture, or no intervention in asthma.哮喘中使用沙丁胺醇或安慰剂、假针刺或不干预。
N Engl J Med. 2011 Jul 14;365(2):119-26. doi: 10.1056/NEJMoa1103319.
4
Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies.对嗜酸性粒细胞性食管炎的遗传剖析为该病的发病机制和治疗策略提供了深入了解。
J Allergy Clin Immunol. 2011 Jul;128(1):23-32; quiz 33-4. doi: 10.1016/j.jaci.2011.03.046. Epub 2011 May 13.
5
Eosinophilic esophagitis: updated consensus recommendations for children and adults.嗜酸粒细胞性食管炎：儿童和成人的最新共识建议。
J Allergy Clin Immunol. 2011 Jul;128(1):3-20.e6; quiz 21-2. doi: 10.1016/j.jaci.2011.02.040. Epub 2011 Apr 7.
6
Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.口服黏性布地奈德在一项随机、安慰剂对照试验中对嗜酸细胞性食管炎患儿有效。
Gastroenterology. 2010 Aug;139(2):418-29. doi: 10.1053/j.gastro.2010.05.001. Epub 2010 May 7.
7
The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature.在临床实践中测量患者报告结局的影响：文献系统综述
Qual Life Res. 2008 Mar;17(2):179-93. doi: 10.1007/s11136-007-9295-0. Epub 2008 Jan 4.
8
Patient-reported outcomes to support medical product labeling claims: FDA perspective.支持医疗产品标签声明的患者报告结果：美国食品药品监督管理局的观点
Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37. doi: 10.1111/j.1524-4733.2007.00275.x.
9
A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.一项关于丙酸氟替卡松治疗儿童嗜酸性粒细胞性食管炎的随机、双盲、安慰剂对照试验。
Gastroenterology. 2006 Nov;131(5):1381-91. doi: 10.1053/j.gastro.2006.08.033. Epub 2006 Aug 16.
Zotero 插件